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Introduction

Materials

One of the hallmarks of cancer is genomic instability. Upon DNA
damage, multiple repair pathways exist, one of which being
homologous recombination (HR). This pathway uses the sister
chromatid as a template to repair the DNA double strand break
(DSB) and is mediated by BRCA1. The BRCA1 gene is a crucial
player in stabilizing genome integrity. Germline breast and
ovarian cancer show high rates of mutation of this gene. HR is
initiated by DNA end resection, creating a long 3’ ssDNA tail that
can invade the homologous DNA strand. The BRCA1-A complex
(Figure 1) is a collection of proteins that work together to repair
DSB. Two crucial proteins of this complex are Abraxas, a scaffold
protein, and BRCA1. When DNA is damaged, ATM signaling
induces ubiquitination of lysines conjugated at the damage site.
RAP80, a protein in the BRCA1-A complex, binds to the
polyubiquitin chain of lysine 63, recruiting BRCA1. Abraxas then
dimerizes and stabilizes BRCA1 at the site, initiating HR.

• Cell lines: U2OS (untreated and treated),
ULF3 (Abraxas KO), ULF3 WT, ULF3
S404S406 double mutant
• 1μM CPT
• FiberPrep® DNA Extraction Kit
• FiberComb® Molecular Combing System
• BrdU antibody
• Fluorescence dye 488
• 80i microscope
• ImageJ software

•
•
•
•
•
•

Comb DNA onto coverslips and bake
Adhere coverslips to slides
Using the 80i microscope, take images of the DNA
fibers
Use ImageJ software to measure the lengths of
the fibers
Compile the data and statistically analyze using
ANOVA
Plot the mean fiber length for each treatment

Conclusions
Based on these preliminary findings, the interaction of
BRCA1 and Abraxas at these interaction points cannot be
conclusively determined. The images produced did not
show distinct ssDNA fibers, making quantification
impossible. Further experimentation is needed to confirm
the results.

Future Directions

Fig. 2 Abraxas KO with WT Abraxas knocked in (ULF3 WT)
cells after CPT treatment, SMART treatment, and staining.
Further experimentation and analysis is necessary to
confirm the presence and quantity of DNA fibers.
Fig. 1: The mechanism detailing the accumulation of
the BRCA1-A complex at the DNA damage site (Wu et
al.)

It has been shown that DNA end resection as a result of
camptothecin (CPT) treatment, a topoisomerase inhibitor, is
inhibited by Abraxas, limiting break-induced replication (BIR).
BIR is a highly mutagenic repair pathway that is initiated by the
collapse of the replication fork and telomere erosion. Crucial to
its function as a tumor suppressor is BRCA1’s ability to
recognize pSPxF motifs on other proteins through its two BRCT
domains. Abraxas and BRCA1 interact at two important points
when they form the BRCA1-A complex: S406 and S404. S406 is
in the SPxF motif in Abraxas’s C-terminus, is phosphorylated in
response to DNA damage, and interacts directly with the BRCT
domain of BRCA1. S404 is near the SPxF motif in Abraxas’s Cterminus. Its phosphorylation is required for dimerization of
BRCA1-BRCT/Abraxas and is crucial for BRCA1 accumulation
at DNA damage sites. Double phosphorylation of S404S406 is
induced by ionizing radiation in an ATM pathway dependent
manner.

Methods
• Culture U2OS cells to have four lines:
U2OS, Abraxas KO (ULF3), ULF3 with WT
Abraxas knocked in, ULF3 with S404S406
double mutant knocked in
• Upon 40-50% confluency, treat cells for 2448 hours with BrdU
• Treat cells for 1 hour with 1μM CPT
• The U2OS cell lines should have two
treatments: CPT treatment and no
CPT treatment
• Count cells and calculate appropriate volume
to all for 1 x 106 cells/plug
• Form plugs
• Plugs are fragile; it is recommended to
have multiples of each treatment
• Digest proteins using FiberPrep® DNA
Extraction Kit Digestion Buffer and wash
• Prepare DNA solution for FiberComb®

• Test if Abraxas S404S406 double mutant affects
Abraxas’s function in inhibition of DNA end resection
and BIR in response to CPT damage
• Survey BIR levels using MiDAS
• Analyze known Abraxas cancer mutations using
SMART and MiDAS
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